Aquestive Therapeutics, Inc. AQST Fixed assets
Fixed assets at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsPropertyPlantAndEquipment.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s fixed assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s fixed assets?
- Aquestive Therapeutics, Inc. (AQST) reported fixed assets of $2.32M in Q4 2025.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s fixed assets?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s fixed assets has grown at a -8.2% compound annual growth rate (CAGR), from $2.76M to $2.32M.